These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29756343)

  • 1. Risk of bladder cancer by disease severity in relation to metabolic factors and smoking: A prospective pooled cohort study of 800,000 men and women.
    Teleka S; Häggström C; Nagel G; Bjørge T; Manjer J; Ulmer H; Liedberg F; Ghaderi S; Lang A; Jonsson H; Jahnson S; Orho-Melander M; Tretli S; Stattin P; Stocks T
    Int J Cancer; 2018 Dec; 143(12):3071-3082. PubMed ID: 29756343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between blood pressure and BMI with bladder cancer risk and mortality in 340,000 men in three Swedish cohorts.
    Teleka S; Jochems SHJ; Häggström C; Wood AM; Järvholm B; Orho-Melander M; Liedberg F; Stocks T
    Cancer Med; 2021 Feb; 10(4):1431-1438. PubMed ID: 33455057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifestyle associated factors and risk of urinary bladder cancer: A prospective cohort study from Norway.
    Hektoen HH; Robsahm TE; Andreassen BK; Stenehjem JS; Axcrona K; Mondul A; Gislefoss RE
    Cancer Med; 2020 Jun; 9(12):4420-4432. PubMed ID: 32319230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure and bladder cancer risk in men by use of survival analysis and in interaction with NAT2 genotype, and by Mendelian randomization analysis.
    Teleka S; Hindy G; Drake I; Poveda A; Melander O; Liedberg F; Orho-Melander M; Stocks T
    PLoS One; 2020; 15(11):e0241711. PubMed ID: 33237904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.
    Borena W; Strohmaier S; Lukanova A; Bjørge T; Lindkvist B; Hallmans G; Edlinger M; Stocks T; Nagel G; Manjer J; Engeland A; Selmer R; Häggström C; Tretli S; Concin H; Jonsson H; Stattin P; Ulmer H
    Int J Cancer; 2012 Jul; 131(1):193-200. PubMed ID: 21805476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can).
    Häggström C; Stocks T; Rapp K; Bjørge T; Lindkvist B; Concin H; Engeland A; Manjer J; Ulmer H; Selmer R; Tretli S; Hallmans G; Jonsson H; Stattin P
    Int J Cancer; 2011 Apr; 128(8):1890-8. PubMed ID: 20568111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can).
    Ulmer H; Bjørge T; Concin H; Lukanova A; Manjer J; Hallmans G; Borena W; Häggström C; Engeland A; Almquist M; Jonsson H; Selmer R; Stattin P; Tretli S; Kleiner A; Stocks T; Nagel G
    Gynecol Oncol; 2012 May; 125(2):330-5. PubMed ID: 22330614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic risk score and cancer risk: pooled analysis of seven cohorts.
    Stocks T; Bjørge T; Ulmer H; Manjer J; Häggström C; Nagel G; Engeland A; Johansen D; Hallmans G; Selmer R; Concin H; Tretli S; Jonsson H; Stattin P
    Int J Epidemiol; 2015 Aug; 44(4):1353-63. PubMed ID: 25652574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthropometric and Metabolic Risk Factors for ESRD Are Disease-Specific: Results from a Large Population-Based Cohort Study in Austria.
    Zitt E; Pscheidt C; Concin H; Kramar R; Lhotta K; Nagel G
    PLoS One; 2016; 11(8):e0161376. PubMed ID: 27537361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic factors and the risk of small intestine cancers: Pooled study of 800 000 individuals in the metabolic syndrome and cancer project.
    Nagel G; Bjørge T; Jaensch A; Peter RS; Häggström C; Lang A; Engeland A; Teleka S; Jirström K; Lindquist D; Stattin P; Ulmer H; Concin H; Stocks T
    Int J Cancer; 2021 Jul; 149(1):66-74. PubMed ID: 33634882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can).
    Strohmaier S; Edlinger M; Manjer J; Stocks T; Bjørge T; Borena W; Häggström C; Engeland A; Nagel G; Almquist M; Selmer R; Tretli S; Concin H; Hallmans G; Jonsson H; Stattin P; Ulmer H
    PLoS One; 2013; 8(1):e54242. PubMed ID: 23372693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of coronary heart disease mortality with risk factors according to length of follow-up and serum cholesterol level in men: the Oslo Study cohort.
    Holme I; Tonstad S
    Eur J Prev Cardiol; 2013 Feb; 20(1):168-75. PubMed ID: 22131130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex- and Time-Dependent Patterns in Risk Factors of End-Stage Renal Disease: A Large Austrian Cohort with up to 20 Years of Follow-Up.
    Pscheidt C; Nagel G; Zitt E; Kramar R; Concin H; Lhotta K
    PLoS One; 2015; 10(8):e0135052. PubMed ID: 26322515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study.
    Borena W; Edlinger M; Bjørge T; Häggström C; Lindkvist B; Nagel G; Engeland A; Stocks T; Strohmaier S; Manjer J; Selmer R; Tretli S; Concin H; Hallmans G; Jonsson H; Stattin P; Ulmer H
    PLoS One; 2014; 9(2):e89368. PubMed ID: 24586723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women.
    Holick CN; Giovannucci EL; Stampfer MJ; Michaud DS
    Int J Cancer; 2007 Jan; 120(1):140-6. PubMed ID: 17036323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression.
    Evers J; Grotenhuis AJ; Aben KKH; Kiemeney LALM; Vrieling A
    PLoS One; 2020; 15(3):e0229384. PubMed ID: 32210471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
    Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
    Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the influence of cigarette smoking on urothelial carcinogenesis: smoking-induced gene expression in tumor-free urothelium might discriminate muscle-invasive from nonmuscle-invasive urothelial bladder cancer.
    Gabriel U; Li L; Bolenz C; Steidler A; Kränzlin B; Saile M; Gretz N; Trojan L; Michel MS
    Mol Carcinog; 2012 Nov; 51(11):907-15. PubMed ID: 21976419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fruit consumption and the risk of bladder cancer: A pooled analysis by the Bladder Cancer Epidemiology and Nutritional Determinants Study.
    Jochems SHJ; Reulen RC; van Osch FHM; Witlox WJA; Goossens ME; Brinkman M; Giles GG; Milne RL; van den Brandt PA; White E; Weiderpass E; Huybrechts I; Hémon B; Agudo A; Bueno-de-Mesquita B; Cheng KK; van Schooten FJ; Bryan RT; Wesselius A; Zeegers MP
    Int J Cancer; 2020 Oct; 147(8):2091-2100. PubMed ID: 32285440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomy.
    Aziz A; Gierth M; Fritsche HM; May M; Otto W; Denzinger S; Wieland WF; Merseburger A; Riedmiller H; Kocot A; Burger M
    Urol Int; 2013; 91(1):97-102. PubMed ID: 23751372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.